Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers

Q: How long will it take to read this news story?

The story "Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers" has 1895 words across 83 sentences, which will take approximately 8 - 16 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers" was covered 1 days ago by Wired, a news publisher based in United States.

Q: How trustworthy is 'Wired' news outlet?

Wired is a fully independent (privately-owned) news outlet established in 1993 that covers mostly technology and economy news. The outlet is headquartered in United States and publishes an average of 15 news stories per day. It's most recent story was published 11 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #23570706</li><li>URL: https://beamstart.com/news/bone-marrow-donors-can-be-17315014906662</li></ul>

Wired 1d ago

Bone Marrow Donors Can Be Hard to Find. One Company Is Turning to Cadavers - Wired

Quick Summary:

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months.

Robert Negrin, a professor of medicine at Stanford University and vice president of the American Society of Hematology, calls the transplants an “important milestone,” but whether the technique will be useful for cancer patients remains to be seen.“We have other options that work pretty well,” he says, referring to partially matched donor transplants and cord blood transplants.“But there are always situations that could fall through the cracks.

But Abidi is confident that deceased donor bone marrow transplants could open up a significant treatment option for minorities.“Once this becomes standard of care,” Abidi says, “this is going to be a game changer.